中文名稱:兔抗CAV3多克隆抗體
英文名稱: Anti-CAV3 rabbit polyclonal antibody
別 名: LQT9; VIP21; LGMD1C; VIP-21
相關(guān)類別: 一抗
儲(chǔ) 存: 冷凍(-20℃)
宿 主: Rabbit
抗 原: CAV3
反應(yīng)種屬: Human
標(biāo) 記 物: Unconjugate
克隆類型: rabbit polyclonal
技術(shù)規(guī)格
Background: |
This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. |
Applications: |
ELISA, WB, IHC |
Name of antibody: |
CAV3 |
Immunogen: |
Synthetic peptide of human CAV3 |
Full name: |
caveolin 3 |
Synonyms: |
LQT9; VIP21; LGMD1C; VIP-21 |
SwissProt: |
P56539 |
IHC positive control: |
Human gastric cancer and human thyroid cancer |
IHC Recommend dilution: |
50-200 |
WB Predicted band size: |
17 kDa |
WB Positive control: |
Human fetal muscle tissue |
WB Recommended dilution: |
500-2000 |